BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

VantAI

VantAI logo

Founded
2019
Geography
United States of America based

VantAI pairs bleeding-edge machine learning techniques with deep systems biology expertise to build computational models that uncover hidden relationships between molecules, targets, and diseases. These models power a best-in-class solution that identifies and generates new molecular entities for targets of interest, repurposes existing molecules at any stage of development, uncovers accurate ADME and toxicological insights, and predicts adverse events likely to influence trial success from deep analysis of systems-based pharmacogenomics. VantAI's in silico platform specializes in modelling complex protein-protein interactions, powering the discovery of biologics and protein degraders in addition to small-molecule drugs. It has helped leading biopharma partners launch new development programs--or revitalize old ones--at a fraction of the time and cost of traditional methods. For more information, please visit http://www.vant.ai.

Technologies

AI Companies (Drug Discovery)   Protein Degraders Startups  

R&D Platform


Pipelines

No pipelines published yet

Products

 

Services

No services posted yet